 |
Introduction |
 |
Investigation of DSD patients |
 |
46,XY DSD due to ABNORMALITIES OF GONADAL DEVELOPMENT |
 |
Gonadal agenesis |
 |
46,XY DSD due to gonadal dysgenesis |
 |
Complete and partial 46,XY gonadal dysgenesis |
 |
Embryonic testicular regression syndrome (ETRS) |
 |
Gonadal dysgenesis associated with syndromic phenotype |
 |
46,XY DSD due to underexpression of WT1 gene |
 |
46,XY DSD due to the underexpression of steroidogenic factor-1 (NR5A1/SF1) |
 |
46,XY DSD due to the underexpression of DMRT1 and DMRT2 genes |
 |
ATR-X syndrome (X-linked -thalassemia and mental retardation |
 |
46,XY DSD due to the overexpression of DAX1 (NR0B1) gene |
 |
46,XY DSD due to the overexpression of WNT4 gene |
 |
Dysgenetic 46,XY DSD associated with campomelic dysplasia (underexpression of the SOX9) |
 |
Dysgenetic 46,XY DSD due to Desert hedgehog (DHH) underexpression |
 |
46,XY DSD ASSOCIATED WITH Cholesterol Synthesis |
 |
46,XY DSD due to testosterone synthesis defects |
 |
46,XY DSD due to Leydig cell hypoplasia (complete and partial forms) |
 |
46,XY DSD due to testosterone synthesis defect |
 |
Defect in Corticosteroid and Testosterone Synthesis |
 |
Congenital lipoid adrenal hyperplasia |
 |
Deficiency of the acute steroidogenesis regulatory protein (StAR) |
 |
Deficiency of P45011A |
 |
Deficiency of the acute steroidogenesis regulatory protein (StAR) |
 |
Deficiency of P450scc |
 |
3b-Hydroxysteroid Dehydrogenase type II Deficiency |
 |
CYP17 (17-Hydroxylase and C-17-20 lyase deficiency) |
 |
Defects in Testicular Steroidogenesis |
 |
CYP17 (17,20 lyase activity) Deficiency |
 |
46,XY DSD due to 17b-HSD 3 Deficiency |
 |
Altered steroidogenesis due to disrupted electron donor proteins |
 |
Cytochrome P450 reductase (POR) deficiency |
 |
Methaemoglobinemia, type IV, with 46,XY DSD due to cytochrome b5 defect |
 |
46,XY DSD due to defects in Testosterone Metabolism |
 |
5-Reductase type 2 Deficiency |
 |
46,XY DSD DUE TO DEFECTS IN ANDROGEN ACTION |
 |
Androgen insensitivity syndrome - complete and partial forms |
 |
PERSISTENT MÜLLERIAN DUCT SYNDROME |
 |
Defect in AMH synthesis |
 |
Defect in AMH receptor |
 |
Congenital NON-GENETIC 46,XY DSD |
 |
Maternal intake of endocrine disruptors |
 |
Congenital non-genetic 46,XY DSD associated to impaired prenatal growth |
 |
46,XY ovotesticular DSD |
 |
Non-Classified Forms |
 |
Hypospadias |
 |
46,XY gender Identity disorders |
 |
Male to female transsexualism |
 |
Management of patients with 46,XY DSD |
 |
Hormonal Therapy |
 |
Surgical Treatment |
 |
Dysgenetic or undescended gonads and tumor development |
 |
Fertility in patients with 46,XY DSD |